Literature DB >> 11675178

Long-term results of coronary artery bypass grafting procedure in the presence of left ventricular dysfunction and hibernating myocardium.

R Lorusso1, G La Canna, C Ceconi, V Borghetti, P Totaro, G Parrinello, G Coletti, G Minzioni.   

Abstract

OBJECTIVE: Long-term left ventricular (LV) performance and patient outcome after coronary artery bypass grafting (CABG) procedure in the presence of depressed LV function and hibernating myocardium (HM) have been poorly determined. Therefore, we prospectively evaluated patients undergoing CABG with severe LV dysfunction and HM to elucidate postoperative prognosis.
METHODS: We enrolled 120 consecutive patients undergoing CABG with severe LV dysfunction and HM as assessed by dobutamine echocardiography and by rest-redistribution radionuclide (Thallium-201) study. Mean patient age was 60+/-9 years (range 31-77 years). Mean preoperative LVEF was 28%+/-9 (range 10-40%). All patients underwent echocardiographic study to assess LV recovery of function intraoperatively, prior to hospital discharge, at 3 months, at 1 year, and yearly during the follow-up. Univariate and multivariate analysis were performed to to evaluate predictors of postoperative survival.
RESULTS: There were 2 hospital (1.6%) and 15 late (12.5%) deaths, mainly for heart failure, leading to an actuarial survival of 80+/-6% and 60+/-9% at 5 and 8 years, respectively. LVEF significantly improved perioperatively (from 28+/-9% to 40+/-2%, P<0.01). Increase in LVEF, however, was gradually offset over the time (EF of 33+/-9%, 32+/-8%, and 30+/-9% at 3 months, and 12 months, and 8 years after surgery, respectively). Furthermore, patients who experienced limited LV functional recovery perioperatively had a more remarkable decline of LVEF thereafter, and suffered from recurrence of heart failure symptoms (freedom from heart failure 82+/-5% and 60+/-8% at 4 and 8 years respectively). Advanced preoperative NYHA Class, and age were independent risks factors for reduced postoperative survival. Preoperative angina and use of arterial conduits apparently did not influence patient morbidity and mortality at long term.
CONCLUSION: CABG procedure in the presence of HM enhances LV recovery of function and has a favourable prognosis. Functional benefit of the left ventricle, however, appears to be time-limited, despite remarkable improvement in patient functional capacity. Advanced preoperative heart failure, minimal perioperative improvement of LVEF, and age account for a poor long-term prognosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11675178     DOI: 10.1016/s1010-7940(01)00945-9

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  14 in total

Review 1.  Surgery for hibernation.

Authors:  J Pepper
Journal:  Heart       Date:  2004-02       Impact factor: 5.994

2.  Systolic heart function remains depressed for at least 30 days after on-pump cardiac surgery.

Authors:  Peter Juhl-Olsen; Rajesh Bhavsar; Christian Alcaraz Frederiksen; Erik Sloth; Carl-Johan Jakobsen
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-06-08

3.  Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial.

Authors:  Roberto Bolli; Atul R Chugh; Domenico D'Amario; John H Loughran; Marcus F Stoddard; Sohail Ikram; Garth M Beache; Stephen G Wagner; Annarosa Leri; Toru Hosoda; Fumihiro Sanada; Julius B Elmore; Polina Goichberg; Donato Cappetta; Naresh K Solankhi; Ibrahim Fahsah; D Gregg Rokosh; Mark S Slaughter; Jan Kajstura; Piero Anversa
Journal:  Lancet       Date:  2011-11-14       Impact factor: 79.321

4.  Revascularization among patients with severe left ventricular dysfunction: a meta-analysis of observational studies.

Authors:  Vijayalakshmi Kunadian; Azfar Zaman; Weiliang Qiu
Journal:  Eur J Heart Fail       Date:  2011-04-08       Impact factor: 15.534

5.  Long-term survival and functional recovery after isolated coronary artery bypass grafting in patients with severe left ventricular dysfunction.

Authors:  Toshihiro Fukui; Toshihiko Shibata; Yasuyuki Sasaki; Hidekazu Hirai; Manabu Motoki; Yosuke Takahashi; Atsushi Nakahira; Shigefumi Suehiro
Journal:  Gen Thorac Cardiovasc Surg       Date:  2007-10

6.  Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonance.

Authors:  Atul R Chugh; Garth M Beache; John H Loughran; Nathan Mewton; Julius B Elmore; Jan Kajstura; Patroklos Pappas; Antone Tatooles; Marcus F Stoddard; Joao A C Lima; Mark S Slaughter; Piero Anversa; Roberto Bolli
Journal:  Circulation       Date:  2012-09-11       Impact factor: 29.690

7.  Cardiac Strain in a Swine Model of Regional Hibernating Myocardium: Effects of CoQ10 on Contractile Reserve Following Bypass Surgery.

Authors:  Laura Hocum Stone; Tammy A Butterick; Cayla Duffy; Corey Swingen; Herbert B Ward; Rosemary F Kelly; Edward O McFalls
Journal:  J Cardiovasc Transl Res       Date:  2016-05-16       Impact factor: 4.132

8.  Coronary surgery with non-cardioplegic methods in patients with advanced left ventricular dysfunction: immediate and long term results.

Authors:  P E Antunes; J M Ferrão de Oliveira; M J Antunes
Journal:  Heart       Date:  2003-04       Impact factor: 5.994

9.  No evidence of myocardial restoration following transplantation of mononuclear bone marrow cells in coronary bypass grafting surgery patients based upon cardiac SPECT and 18F-PET.

Authors:  Paschalis Tossios; Jochen Müller-Ehmsen; Matthias Schmidt; Christof Scheid; Nermin Unal; Detlef Moka; Robert H G Schwinger; Uwe Mehlhorn
Journal:  BMC Med Imaging       Date:  2006-07-14       Impact factor: 1.930

10.  Echocardiographic Evaluation of the Effects of a Single Bolus of Erythropoietin on Reducing Ischemia-Reperfusion Injuries during Coronary Artery Bypass Graft Surgery; A Randomized, Double-Blind, Placebo-Control Study.

Authors:  Shervin Ziabakhsh-Tabary; Rozita Jalalian; Farzad Mokhtari-Esbuie; Mohammad Reza Habibi
Journal:  Iran J Med Sci       Date:  2014-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.